Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 5 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4188.23 | 578 / 578 | 96% | 14.32 | 1112 / 1155 |
ovary | 100% | 4553.56 | 180 / 180 | 87% | 9.23 | 376 / 430 |
thymus | 96% | 1726.38 | 630 / 653 | 82% | 12.33 | 494 / 605 |
breast | 98% | 1340.95 | 449 / 459 | 75% | 7.53 | 841 / 1118 |
kidney | 88% | 1580.07 | 78 / 89 | 84% | 12.41 | 761 / 901 |
bladder | 81% | 1205.76 | 17 / 21 | 84% | 8.67 | 421 / 504 |
stomach | 76% | 751.46 | 272 / 359 | 86% | 10.63 | 247 / 286 |
intestine | 77% | 1755.91 | 742 / 966 | 82% | 8.27 | 430 / 527 |
uterus | 72% | 789.06 | 122 / 170 | 84% | 10.20 | 387 / 459 |
esophagus | 59% | 578.78 | 846 / 1445 | 87% | 10.63 | 160 / 183 |
prostate | 93% | 1518.60 | 229 / 245 | 48% | 2.97 | 242 / 502 |
adrenal gland | 84% | 754.10 | 216 / 258 | 48% | 5.78 | 110 / 230 |
skin | 44% | 331.17 | 793 / 1809 | 86% | 15.03 | 408 / 472 |
pancreas | 27% | 196.34 | 88 / 328 | 96% | 13.31 | 170 / 178 |
brain | 73% | 713.88 | 1934 / 2642 | 42% | 3.75 | 296 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 103.87 | 29 / 29 |
peripheral blood | 100% | 22450.81 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 16978.85 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 1667.09 | 1168 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 21.48 | 42 / 45 |
liver | 46% | 394.16 | 103 / 226 | 40% | 3.63 | 161 / 406 |
blood vessel | 51% | 623.76 | 684 / 1335 | 0% | 0 | 0 / 0 |
heart | 48% | 486.83 | 413 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 2.03 | 23 / 80 |
muscle | 4% | 27.51 | 34 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043029 | Biological process | T cell homeostasis |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0038110 | Biological process | interleukin-2-mediated signaling pathway |
GO_0038113 | Biological process | interleukin-9-mediated signaling pathway |
GO_0007260 | Biological process | tyrosine phosphorylation of STAT protein |
GO_0035723 | Biological process | interleukin-15-mediated signaling pathway |
GO_0002731 | Biological process | negative regulation of dendritic cell cytokine production |
GO_0045087 | Biological process | innate immune response |
GO_0060397 | Biological process | growth hormone receptor signaling pathway via JAK-STAT |
GO_0007167 | Biological process | enzyme-linked receptor protein signaling pathway |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0070232 | Biological process | regulation of T cell apoptotic process |
GO_0032695 | Biological process | negative regulation of interleukin-12 production |
GO_0071104 | Biological process | response to interleukin-9 |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0035771 | Biological process | interleukin-4-mediated signaling pathway |
GO_0002250 | Biological process | adaptive immune response |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0070669 | Biological process | response to interleukin-2 |
GO_0030154 | Biological process | cell differentiation |
GO_0046425 | Biological process | regulation of receptor signaling pathway via JAK-STAT |
GO_0070670 | Biological process | response to interleukin-4 |
GO_0045221 | Biological process | negative regulation of FasL production |
GO_0070672 | Biological process | response to interleukin-15 |
GO_0045626 | Biological process | negative regulation of T-helper 1 cell differentiation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0030183 | Biological process | B cell differentiation |
GO_0070244 | Biological process | negative regulation of thymocyte apoptotic process |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0031234 | Cellular component | extrinsic component of cytoplasmic side of plasma membrane |
GO_0019897 | Cellular component | extrinsic component of plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005768 | Cellular component | endosome |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005131 | Molecular function | growth hormone receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | JAK3 |
Protein name | Janus kinase 3 Tyrosine-protein kinase (EC 2.7.10.2) Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) |
Synonyms | |
Description | FUNCTION: Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, upon IL2R activation by IL2, JAK1 and JAK3 molecules bind to IL2R beta (IL2RB) and gamma chain (IL2RG) subunits inducing the tyrosine phosphorylation of both receptor subunits on their cytoplasmic domain. Then, STAT5A and STAT5B are recruited, phosphorylated and activated by JAK1 and JAK3. Once activated, dimerized STAT5 translocates to the nucleus and promotes the transcription of specific target genes in a cytokine-specific fashion. . |
Accessions | ENST00000526008.6 ENST00000458235.7 [P52333-1] P52333 A0A0S2Z4R7 ENST00000534444.1 [P52333-2] A0A0S2Z485 ENST00000527670.5 [P52333-1] |